Navigation Links
Inverness Medical Innovations Announces Third Quarter 2008 Results
Date:10/29/2008

Restricted cash 3,593 141,869

Marketable securities 1,994 2,551

Accounts receivable, net 268,373 163,380

Inventories, net 196,646 148,231

Prepaid expenses and other current

assets 101,100 82,211

Total current assets 725,876 952,974

PROPERTY, PLANT AND EQUIPMENT, NET 287,272 267,880

GOODWILL AND OTHER INTANGIBLE ASSETS,

NET 4,790,352 3,494,174

DEFERRED FINANCING COSTS AND OTHER

ASSETS, NET 139,678 165,731

Total assets $5,943,178 $4,880,759

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:

Current portion of notes payable $20,005 $21,096

Other current liabilities 364,807 257,812

Total current liabilities 384,812 278,908

LONG-TERM LIABILITIES:

Notes payable, net of current portion 1,505,510 1,366,753

Deferred tax liability 442,446 326,128

Other long-term liabilities 342,934 322,303

Total long-term liabilities 2,290,890 2,015,184

TOTAL STOCKHOLDERS' EQUITY 3,267,476 2,586,667

Total liabilities and stockholders'

equity $5,943,178 $4,880,759


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
2. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
3. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
4. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
5. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
6. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
7. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
8. Inverness Medical Innovations Announces Second Quarter 2008 Results
9. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
10. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
11. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... 7 Voler Systems ( http://www.volersystems.com ) has launched ... provides full-service consulting from concept and design to production ... are not deterring Voler from investing in key programs ... reducing time-to-market for new medical devices. During the economic ...
... Ltd. announced,today that the U.S. Food and Drug Administration ... MR-guided Focused Ultrasound,(MRgFUS) system for the treatment of women ... agency allows,physicians to treat up to 100% of the ... to half the fibroid tissue. , ...
... Enhanced Functionality Empowers Users to Take Full Control ... from Assessment to Results Disclosure - while Adhering ... Choose PharmaCM to Manage Their Clinical Trial Registration ... Intrasphere Technologies ( http://www.intrasphere.com ...
Cached Biology Technology:Voler Systems Continues Investments and Expands Services 2FDA Approves Label Change for Non-Invasive Fibroid Treatment 2FDA Approves Label Change for Non-Invasive Fibroid Treatment 3Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft 2Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft 3Intrasphere Technologies Releases Version 1.5 of Its PharmaCM Clinical Trial Registration Solution Powered by Microsoft 4
(Date:12/17/2014)... Dec. 16, 2014  Automation is fundamentally transforming ... evident than at international borders. Over the past ... have allowed veteran travelers to self process through ... (APC) Kiosks at an increasing number of airports, ... According to Maxine Most , ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences ... monitoring, has released a new series of digital ... preclinical toxicology researchers. M series, part of the ... collect the best possible physiologic data when incorporating ... Adding functional endpoints to toxicology studies has evolved ...
(Date:12/10/2014)... DUBLIN , Dec. 08, 2014 Research ... announced the addition of the "Biometrics Market ... http://photos.prnewswire.com/prnh/20130307/600769 ... for projects such as rural banking and upgradation ... major trends witnessed in the market. Besides the ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... created an ultrasensitive biosensor that could open up ... "personalized medicine" tailored to the specific biochemistry of ... several hundred times more sensitive than other biosensors, ... of sensors, said Muhammad A. Alam, a Purdue ...
... of many crucial molecules (such as DNA) and is a ... is a major environmental stress for plants and can lead ... their own phosphorus; they get all they need at the ... one way to maximise the amount of phosphorus in the ...
... NEW YORK, NY (May 14, 2012) -- Dr. Darja Marolt, ... Laboratory, is lead author on a study showing that human ... grafts for use in research and potential therapeutic application. Dr. ... Fellow at Columbia University in the laboratory of Dr. Gordana ...
Cached Biology News:Ultrasensitive biosensor promising for medical diagnostics 2When the soil holds not enough phosphorus 2
Request Info...
...
... potent inhibition of RNase A-type ribonucleases Product ... of nonhuman origin that binds noncovalently and ... A, B, and C). It does not ... U2, or CL3. QIAGEN RNase Inhibitor inhibits ...
Request Info...
Biology Products: